| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00417-018-4194-3 |
| P698 | PubMed publication ID | 30552510 |
| P50 | author | Jae Chan Kim | Q90529016 |
| P2093 | author name string | Yeoun Sook Chun | |
| Jeong Kyu Lee | |||
| Jeong Woo Kang | |||
| Min Gyu Choi | |||
| Joon Hyung Yeo | |||
| P2860 | cites work | Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study | Q33740130 |
| Noncosmetic periocular therapeutic applications of botulinum toxin | Q33941058 | ||
| Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: therapeutic implications for migraine and other pains | Q34207258 | ||
| Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery | Q34282549 | ||
| Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye | Q34529869 | ||
| Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. | Q34544207 | ||
| Aging and the lacrimal system | Q35298365 | ||
| Human Tear Serotonin Levels Correlate with Symptoms and Signs of Dry Eye | Q35893589 | ||
| Serotonin in pain and analgesia: actions in the periphery | Q35913880 | ||
| Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology | Q36152069 | ||
| Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia | Q37714487 | ||
| The complex role of serotonin and 5-HT receptors in chronic pain | Q37909884 | ||
| A review of the complications of lacrimal occlusion with punctal and canalicular plugs | Q38001489 | ||
| TFOS DEWS II pathophysiology report | Q38652987 | ||
| TFOS DEWS II Definition and Classification Report. | Q38665717 | ||
| The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye | Q38724515 | ||
| Dry eye symptom severity and persistence are associated with symptoms of neuropathic pain. | Q44054312 | ||
| Treatment of superior limbic keratoconjunctivitis with a large-diameter contact lens and Botulium Toxin A. | Q45941457 | ||
| Chemical mediators enhance the excitability of unmyelinated sensory axons in normal and injured peripheral nerve of the rat. | Q46615266 | ||
| Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay | Q47374338 | ||
| Changes in ocular higher-order aberrations following botulinum toxin treatment in patients with blepharospasm : BTX improves dry eye in patients with BEB. | Q47637693 | ||
| Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production | Q47929630 | ||
| Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye. | Q51677759 | ||
| A quantitative assessment of the location and width of Marx's line along the marginal zone of the human eyelid. | Q51836903 | ||
| Serotonin in human tears | Q72404825 | ||
| Effect of eyelid botulinum toxin injection on lacrimal drainage | Q73676016 | ||
| Botulinum toxin increases tearing in patients with Sjögren's syndrome: a preliminary report | Q73687023 | ||
| Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
| P433 | issue | 2 | |
| P921 | main subject | eye disease | Q3041498 |
| botulinum toxin type A | Q4095199 | ||
| P304 | page(s) | 331-338 | |
| P577 | publication date | 2018-12-14 | |
| P1433 | published in | Graefe's Archive for Clinical and Experimental Ophthalmology | Q15757667 |
| P1476 | title | Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines | |
| P478 | volume | 257 |
Search more.